Medical expert of the article

Endocrinologist

New publications

Pancreatic tumors with carcinoid syndrome

Alexey Portnov, medical expert
Last reviewed: 23.04.2024

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Symptoms
Where does it hurt?
Diagnostics

What do need to examine?
How to examine?
Treatment
Who to contact?

In most cases, they are found in the intestine in the area of the ileocecal angle and in the bronchi, while they are rarely functioning.

Pancreatic carcinoid is capable of secreting virtually all peptides that are characteristic of ortho- and para- endocrine neoplasms.

trusted-source [1], [2], [3], [4]

Symptoms of the pancreatic tumors with carcinoid syndrome

Carcinoid syndrome is caused by the secretion of biogenic amines and is clinically manifested by hot flashes, tachycardia, diarrhea and attacks of bronchial asthma. The presence of clinical manifestations indicates the overcoming of the hepatic barrier by biogenic amines as a result of the metastatic process.

Where does it hurt?

Pain in the pancreas

Pain in the left side

Diagnostics of the pancreatic tumors with carcinoid syndrome

Laboratory diagnostics allows revealing high levels of serotonin, histamine and 5-hydroxytryptophan in the blood of patients, as well as increased urinary excretion of 5-hydroxyindoleacetic acid.

trusted-source [5], [6], [7]

What do need to examine?

Pancreas

Endocrine part of the pancreas

How to examine?

Pancreas ultrasound

X-ray of the pancreas

Diagnosis of the pancreas

Who to contact?

Oncologist

Treatment of the pancreatic tumors with carcinoid syndrome

Medical treatment of carcinoid syndrome consists in the combined use of antagonists of H1 and H2 receptors of histamine or methyldopa. There are observations of the positive effect of the use of somatostatin.